Probiotics: Which and when?

Digestive Diseases

Volumn 26, Issue 2, 2008, Pages 175-182

  Scarpellini, E ^a,b   Cazzato, A ^a   Lauritano, C ^a   Gabrielli, M ^a   Lupascu, A ^a   Gerardino, L ^a   Abenavoli, L ^a   Petruzzellis, C ^a   Gasbarrini, G ^a   Gasbarrini, A ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Functional foods; Gut; Intestine functions; Microbiota; Probiotics

Indexed keywords

PROBIOTIC AGENT;

ALLERGIC DISEASE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; ATOPY; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; DIARRHEA; DRUG USE; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; EVIDENCE BASED MEDICINE; GASTROINTESTINAL DISEASE; INFECTION; INTESTINE FLORA; INTESTINE FUNCTION; IRRITABLE COLON; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LIVER CIRRHOSIS; LOW DRUG DOSE; MONEY; PRIORITY JOURNAL; REVIEW; SEPSIS;

GASTROINTESTINAL DISEASES; HUMANS; INTESTINES; PROBIOTICS;

EID: 42449129343     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000116776     Document Type: Review

References (71)

1. Guraner F, Malagelada JR: Gut flora in health and in disease. Lancet 2003;361:512-519.
2. Gilmore MS, Ferretti JJ: The thin line between gut commensal and pathogen. Science 2003;299:1999-2002.
3. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI: Host-bacterial mutualism in the human intestine. Science 2005;307:1915-1920.
4. MacDonald TT, Monteleone G: Immunity, inflammation and allergy in the gut. Science 2005;307:1920-1928.
5. Marteau P: Role of the intestinal flora in gastrointestinal diseases. Lancet 2000;356:S28.
6. Hart AL, Lammers K, Brigidi P, et al: Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004;53:1602-1609.
7. Hudspith BN, Rouzard G, Gibson GR, et al: Probiotic bacteria inhibit epithelial cell IL-8 production: role of TLR receptor engagement. Gut 2006;55(suppl 2):A38.
8. Mylonaki M, Rayment NB, Rampton DS, Hudspith BN, Brostoff J: Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis 2005;11:481-487.
9. Pedersen G, Andersen L, Matthiessen MW, Rask-Madsen J, Brynskov J: Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium. Clin Exp Immunol 2005;141:298-306.
10. Swidsinski A, Ladhoff A, Pernthaler A, et al: mucosal flora in inflammatory bowel disease. Gastroenterology 2002;122:44-54.
11. Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF: Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 2004;145:612-616.
12. Del Piano M, Morelli L, Strozzi GP, et al: Probiotics: from research to consumer. Dig Liver Dis 2006;38S:S248-S255.
13. Parvez S, Malik KA, Kang SA, Kim HY: Probiotics and their fermented food products are beneficial for health. J Appl Microbiol 2006;100: 1171-1185.
14. Parkers GC: An overview of probiotics and prebiotics. Nurs Stand 2007;21:43-47.
15. Floch MH, Madsen KK, Jenkins D, et al: Recommendations for probiotic use. J Clin Gastroenterol 2006;40: 275-278.
16. Pineiro M, Stanton C: Probiotic bacteria: legislative framework requirements to evidence basis. J Nutr 2007;137:850S-853S.
17. Menrad K: Market and marketing of functional food in Europe. J Food Eng 2003;56:181-188.
18. Delgado S, Suarez A, Mayo B: Identification of dominant bacteria in feces and colonic mucosa from healthy Spanish adults by culturing and by 16S rDNA sequence analysis. Dig Dis Sci 2006;51:744-751.
19. Hungin AP, Whorwell PJ, Tack J, Mearin F: The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003;17:643-650.
20. Bausserman M, Michail S: The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind control trial. J Pediatr 2005;147:197-201.
21. Verdu EF, Collins SM: Irritable bowel syndrome and probiotics: from rationale to clinical use. Curr Opin Gastroenterol 2005;21:697-701.
22. Camilleri M: Probiotics and irritable bowel syndrome: rationale putative mechanisms, and evidence of clinical efficacy. J Clin Gastroenterol 2006;40: 264-269.
23. Kim HJ, Vazquez RM, Camilleri M, et al: A randomized, controlled trial of a probiotic combination, VSL#3 , in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005;17:687-696.
24. Michetti P, Dorta PH, Wiesel D, et al: Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La 1 on Helicobacter pylori infection in humans. Digestion 1999;60: 203-209.
25. Bazzoli F, Zagari RM, Fossi S: In vivo Helicobacter pylori clearance failure with Lactobacillus acidophilus . Gastroenterology 1992;102:A38.
26. Bazzoli F, Zagari RM, Fossi S: In vivo Helicobacter pylori clearance failure with Lactobacillus acidophilus . Gastroenterology 1992;102:A38.
27. Canducci F, Armuzzi A, Cremonini F, et al: A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 2000;14:1625-1629.
28. Cremonini F, Di Caro S, Covino M, et al: Effect of different probiotic preparations on anti- Helicobacter pylori therapy-related side effects: a parallel-group, triple-blind, placebo-controlled study. Am J Gastroenterol 2002;97:2744-2749.
29. Nista EC, Candelli M, Cremonini F, et al: Bacillus clausii therapy to reduce side effects of anti- Helicobacter pylori treatment: randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 2004;15:1181-1188.
30. De Vrese M, Marteau PR: Probiotics and prebiotics: effects on diarrhea. J Nutr 2007;137:803S-811S.
31. Isolauri E, Juntue M, Rauntanen T, Sillanaukee P, Koivula T: A human Lactobacillus strain (Lactobacillus casei sp. strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991;88:90-97.
32. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J: Protection from gastrointestinal diseases using probiotics. Am J Clin Nutr 2001;73:S430-S436.
33. Szajewska H, Mrukowicz JZ: Use of probiotics in children with acute diarrhea. Paediatr Drugs 2005;7:111-122.
34. Allan SJ, Okoko B, Martinez E, Gregorio G, Dans LE: Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2004;2:CD003048.
35. Cremonini F, Di Caro S, Nista E, et al: Metaanalysis: the effect of probiotic administration on antibiotic-associated diarrhea. Aliment Pharm Ther 2002;16:1461-1467.
36. Gaon D, Garmendia C, Murrielo NO, et al: Effect of Lactobacillus strains (L. casei and L. acidophilus strains cerela) on bacterial overgrowth-related chronic diarrhea. Medicina (B Aires) 2002;62:159-163.
37. Gionchetti P, Rizzello F, Venturi A, et al: Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119:305-309.
38. Bibiloni R, Fedorak RN, Tannock GW, et al: VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005;100: 1539-1546.
39. Lindsay JO, Whelan J, Stagg AJ, et al: Clinical, microbiological, and immunological effect of fructo-oligosaccharide in patients with Crohn's disease. Gut 2006;55:348-355.
40. Marteau P, Flourie B, Pochart F, Chastang C, Desieux JF, Rambaud JC: Effect of the microbial lactase (EC 3.2.1.23) activity in yoghurt on the intestinal absorption of lactose: an in vivo study in lactase-deficient humans. Br J Nutr 1990;64:71-79.
41. Zhong Y, Priebe MG, Vonk RJ, et al: The role of colonic microbiota in lactose intolerance. Dig Dis Sci 2004;49:78-83.
42. Sanders ME: Summary of the conclusions from a consensus panel of experts on health attributes on lactic cultures: significance to milk fluid products containing cultures. J Dairy Sci 1993;76:1819-1828.
43. Solga SF: Probiotics can treat hepatic encephalopathy. Med Hypotheses 2003;61:307-313.
44. Shanahan F: Inflammatory bowel diseases: immunodiagnostics, immunotherapeutics and ecotherapeutics. Gastroenterology 2001;120:622-635.
45. Li Z, Yang S, Lin H, et al: Probiotics and antibodies to TNF inhibit inflammatory activity and improve non-alcoholic fatty liver disease. Hepatology 2003;37:343-350.
46. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S: Probiotics in the management of atopic eczema. Clin Exp Allergy 2000;30:1604-1610.
47. Murch SH: Toll of allergy reduced by probiotics. Lancet 2001;357:1057-1059.
48. Kalliomaki MA, Isolauri E: Probiotics and down-regulation of the allergic response. Immunol Allergy Clin North Am 2004;24:739-752.
49. Isolauri E: Dietary modification of atopic disease: use of probiotics in the prevention of atopic dermatitis. Curr Allergy Asthma Rep 2004;4:270-275.
50. Majamaa H, Isolauri E: Probiotics: a novel approach in the management of food allergy. J Allergy Immunol 1997;99:179-183.
51. Cunningham-Rundles S, Ahrne S, Bengmark S, et al: Probiotics and immune response. Am J Gastroenterol 2001;95:S22-S25.
52. Wagner RD, Wagner T, Roberts L: Colonization of congenitally immunodeficient mice with probiotic bacteria. Infect Immun 1997;65:3345-3351.
53. McLean NW, Rosenstein IJ: Characterization and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. J Med Microbiol 2000;49:543-552.
54. Reid G, Bruce AW: Could probiotics be an option for treating and preventing urogenital infections. Medscape Womens Health 2001;6:9.
55. Yukuchi H, Goto T, Okonogi S: The nutritional and physiological value of fermented milks and lactic milk drinks. Diabetes Care 1992;17:13-17.
56. Vanderhoof JA: Probiotics and intestinal inflammatory disorders in infants and in children. J Pediatr Gastroenterol Nutr 2000;30:S34-S38.
57. Aso Y, Akazan H: Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol Int 1992;49:125-129.
58. Aso Y, Akazan H, Kotake T, Tsukamoto T, Imai K: Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. Eur Urol 1995;27:104-109.
59. Salikali J, Picard V, Freitas M, Holt P: Fermented milks, probiotic cultures, and colon cancer. Nutr Cancer 2004;49:14-24.
60. Taranto MP, Medici M, Perdignon G, Ruiz Holgado AP, Valdez GF: Evidence for hypocholesterolemic effect of Lactobacillus reuteri in hypercholesterolemic mice. J Dairy Sci 1998;81:2336-2340.
61. Parvez S, Kim HY, Lee HC, Kim DS: Bile salt hydrolase and cholesterol removal effect by Bifidobacterium bifidum NRRL 1976. World J Microbiol Biotechnol 2006;22:455-459.
62. Sanders ME, Klaenhammer TR: The scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J Dairy Sci 2001;84:319-324.
63. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T: A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 1996;64:767-771.
64. Nakamura Y, Yamamoto N, Sakal K, Takano T: Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin-1-converting enzyme. J Dairy Sci 1995;78:1253-1257.
65. De Vrese M, Rautenberg P, Laue C, Koopmans M, Herremans T, Schrezenmeir J: Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. Eur J Nutr 2005;44:406-413.
66. Transiento OA, Cheremshenko NL, Titova GP, et al: Elevation of the efficacy of antitumor vaccine prepared on the base of lectins from B. subtilis B-7025 upon its combined application with probiotics in vivo. Exp Oncol 2005;27:336-338.
67. Mota RM, Moreira JL, Souza MR, et al: Genetic transformation of novel isolates of chicken Lactobacillus bearing probiotic features for expression of heterologous proteins: a tool to develop live oral vaccines. BMC Biotechnol 2006;6:2.
68. Kukkonen K, Nieminen T, Poussa T, Savilahti E, Kuitunen M: Effect of probiotics on vaccine antibody response in infancy: A randomized, placebo-controlled, double-blind trial. Pediatr Allergy Immunol 2006;17:416-421.
69. Adams MR, Marteau P: On the safety of lactic acid bacteria from food. Int J Food Microbiol 1995;27:263-264.
70. Ishobashi N, Yamazki S: Probiotics and safety. Am J Clin Nutr 2001;73S:465-470.
71. Marteau P, Shanahan F: Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. Best Pract Res Clin Gastroenterol 2003;17:725-740.